Highlights Attana AB

Equities

ATANA

SE0010547273

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.081 ^SEK	+12.50%		+8.00%	-18.18%

Apr. 30	BioInvent Announces Evaluating Attana Technology	CI
Apr. 25	Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioInvent Announces Evaluating Attana Technology	Apr. 30	CI
Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US	Apr. 25	CI
Attana AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Attana Lands Order for Kinetic Interaction Analysis of Tissue in US	Dec. 04	MT
Attana AB Receives Breakthrough Order with New Customer in the USA	Dec. 04	CI
Customer Develops Therapeutic Antibodies Against Cancer and Uses Attana's Cell-Based Technology	Nov. 23	CI
Attana AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Attana AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-29	CI
Attana AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Attana AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-23	CI
Attana AB Submits International Patent Application	23-02-14	CI
Attana AB and 19 Plus AB Sign Collaboration Agreement of Marketing and Sales of Attana Individual Immunity Profiles	23-02-02	CI
Attana Submits New Patent Application Regarding Neutralizing Effect in Complex Samples	22-12-20	CI
Attana AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
Attana AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-18	CI
Attana AB Extends Collaborative Research Agreement with Leading Us Academic Medical Center for Biomedical Research	22-06-23	CI
Attana AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-24	CI
Attana AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Attana Submits New Patent Application	22-02-18	CI
Attana AB Receives A Cell™ 250 Instrument Order from A European Life Science Company	22-02-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Attana AB

Equities

ATANA

SE0010547273

Highlights

Filters